Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea - PubMed (original) (raw)
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea
Banny S Wong et al. Clin Gastroenterol Hepatol. 2012 Sep.
Abstract
Background & aims: Variations in genes that regulate bile acid (BA) synthesis are associated with colonic transit in patients with irritable bowel syndrome (IBS). We investigated features of BA synthesis and excretion and genetic features of patients with different types of IBS.
Methods: In 26 healthy volunteers, 26 patients with IBS and constipation (IBS-C), and 26 with IBS and diarrhea (IBS-D), we measured serum levels of 7α-hydroxy-4-cholesten-3-one (C4; a surrogate for BA synthesis) and fibroblast growth factor (FGF) 19 (an ileal hormone that downregulates BA synthesis). For stool samples, we measured concentration of BA, weight, and amount of fat when participants were given high-fat diets. Spearman correlations were used to explore relationships among factors. We analyzed 1 polymorphism in Klotho-β (KLB) and 3 in fibroblast growth factor receptor-4 (FGFR4) for all members of each group using analysis of covariance.
Results: The concentration of BA in stool was associated with group (for a comparison of 3 groups; P = .057); it was higher in patients with IBS-D than IBS-C (P = .017). The serum level of C4 was higher in patients with IBS-D than IBS-C (P = .02) or healthy volunteers (P = .01); 38% of patients with IBS-D had increased serum levels of C4, compared with healthy volunteers. Serum level of C4 correlated with stool concentration of BA (rs = 0.606; P < .001), serum FGF19 (rs = -0.324; P = .007), and stool weight (rs = 0.366; P = .003). Stool concentration of BA correlated with weight (rs = 0.737; P < .001) and level of fat (rs = 0.528; P < .001). Body mass index correlated with serum level of C4 (rs = 0.423, P < .001) and stool concentration of BA (rs = 0.507, P < .001), and was higher in patients with IBS-D compared with other groups (overall P = .036). FGFR4 rs1966265 was associated with stool level of BA (P = .032).
Conclusions: Patients with IBS-D have greater body mass index and synthesize and excrete higher levels of BA than individuals with IBS-C or healthy volunteers. Serum levels of C4 might be used to identify patients with IBS-D who have BA malabsorption; studies are needed to determine if some patients have a genetic predisposition to this disorder.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
The authors disclose no conflicts.
Figures
Figure 1
(A) Association of fasting serum C4 and subgroup. There was a significant overall univariate association with group and a significant difference between IBS-D and both HV and IBS-C groups. (B) Association of fasting serum C4 and serum FGF19; note the significant negative association, based on Spearman correlation. Inset, the same data are plotted based on rank transformation, and the line demonstrates the inverse correlation between serum FGF19 and C4.
Figure 2
Association of total 48-hour stool BA and subgroup. There was a borderline overall univariate association with group and a significant difference between IBS-D and IBS-C groups.
Figure 3
Relationship between fasting serum C4 and total 48-hour stool BA excretion (A) and total 48-hour stool weight (B).
Figure 4
Relationship between total 48-hour stool weight (A) and stool fat (B) and total 48-hour stool BA excretion.
Figure 5
Relationship between BMI and total stool BA excretion.
Comment in
- [Is the colon oversalted in irritable bowel syndrome?].
Gebbensleben OH. Gebbensleben OH. Z Gastroenterol. 2014 Feb;52(2):224-5. doi: 10.1055/s-0033-1356373. Epub 2014 Feb 13. Z Gastroenterol. 2014. PMID: 24526408 German. No abstract available.
Similar articles
- Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Camilleri M, et al. Am J Gastroenterol. 2014 Oct;109(10):1621-30. doi: 10.1038/ajg.2014.215. Epub 2014 Jul 29. Am J Gastroenterol. 2014. PMID: 25070056 Free PMC article. - Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Camilleri M, et al. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G508-16. doi: 10.1152/ajpgi.00178.2014. Epub 2014 Jul 10. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 25012842 Free PMC article. - Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
Vijayvargiya P, Busciglio I, Burton D, Donato L, Lueke A, Camilleri M. Vijayvargiya P, et al. Clin Gastroenterol Hepatol. 2018 Apr;16(4):522-527. doi: 10.1016/j.cgh.2017.06.039. Epub 2017 Jun 27. Clin Gastroenterol Hepatol. 2018. PMID: 28666948 Free PMC article. - Bile Acid diarrhea: prevalence, pathogenesis, and therapy.
Camilleri M. Camilleri M. Gut Liver. 2015 May 23;9(3):332-9. doi: 10.5009/gnl14397. Gut Liver. 2015. PMID: 25918262 Free PMC article. Review. - The Role of Bile Acids in Chronic Diarrhea.
Camilleri M, Vijayvargiya P. Camilleri M, et al. Am J Gastroenterol. 2020 Oct;115(10):1596-1603. doi: 10.14309/ajg.0000000000000696. Am J Gastroenterol. 2020. PMID: 32558690 Free PMC article. Review.
Cited by
- What is irritable bowel syndrome?
Whorwell PJ. Whorwell PJ. Therap Adv Gastroenterol. 2012 Nov;5(6):379-80. doi: 10.1177/1756283X12461061. Therap Adv Gastroenterol. 2012. PMID: 23152730 Free PMC article. No abstract available. - New insights into irritable bowel syndrome: from pathophysiology to treatment.
Hadjivasilis A, Tsioutis C, Michalinos A, Ntourakis D, Christodoulou DK, Agouridis AP. Hadjivasilis A, et al. Ann Gastroenterol. 2019 Nov-Dec;32(6):554-564. doi: 10.20524/aog.2019.0428. Epub 2019 Oct 22. Ann Gastroenterol. 2019. PMID: 31700231 Free PMC article. Review. - Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Johnston IM, Nolan JD, Pattni SS, Appleby RN, Zhang JH, Kennie SL, Madhan GK, Jameie-Oskooei S, Pathmasrirengam S, Lin J, Hong A, Dixon PH, Williamson C, Walters JR. Johnston IM, et al. Am J Gastroenterol. 2016 Mar;111(3):423-32. doi: 10.1038/ajg.2015.424. Epub 2016 Feb 9. Am J Gastroenterol. 2016. PMID: 26856750 - Archaea influence composition of endoscopically visible ileocolonic biofilms.
Orgler E, Baumgartner M, Duller S, Kumptisch C, Hausmann B, Moser D, Khare V, Lang M, Köcher T, Frick A, Muttenthaler M, Makristathis A, Moissl-Eichinger C, Gasche C. Orgler E, et al. Gut Microbes. 2024 Jan-Dec;16(1):2359500. doi: 10.1080/19490976.2024.2359500. Epub 2024 Jun 2. Gut Microbes. 2024. PMID: 38825783 Free PMC article. - Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.
Ikechi R, Fischer BD, DeSipio J, Phadtare S. Ikechi R, et al. Healthcare (Basel). 2017 Apr 26;5(2):21. doi: 10.3390/healthcare5020021. Healthcare (Basel). 2017. PMID: 28445436 Free PMC article. Review.
References
- Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131. - PubMed
- Eusufzai S. Bile acid malabsorption in patients with chronic diarrhoea. Scand J Gastroenterol. 1993;28:865–868. - PubMed
- Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol. 2007;102:2520–2528. - PubMed
- Sciarretta G, Furno A, Morrone B, et al. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Am J Gastroenterol. 1994;89:1058–1061. - PubMed
- Wedlake L, A’Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30:707–717. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK092179/DK/NIDDK NIH HHS/United States
- RC1 DK086182/DK/NIDDK NIH HHS/United States
- 1RC1-DK086182/DK/NIDDK NIH HHS/United States
- R01-DK092179/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous